Pt Phapros Tbk
PT Phapros Tbk, a prominent player in Indonesia's pharmaceutical industry, is headquartered in Semarang, Central Java. Established in 1971, the company has evolved significantly, marking key milestones in its commitment to healthcare innovation and quality. Specialising in the production of generic medicines, over-the-counter products, and herbal supplements, PT Phapros Tbk distinguishes itself through rigorous quality control and a diverse product portfolio. The company serves various regions across Indonesia, ensuring accessibility to essential healthcare solutions. With a strong market position, PT Phapros Tbk has garnered recognition for its contributions to public health, making it a trusted name in the pharmaceutical sector. Its dedication to research and development continues to drive its growth and enhance its reputation within the industry.
DitchCarbon Score
How does Pt Phapros Tbk's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pt Phapros Tbk's score of 14 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pt Phapros Tbk's reported carbon emissions
In 2023, PT Phapros Tbk reported no specific carbon emissions data, with emissions data for 2024 yet to be disclosed. However, the company has inherited emissions data from its parent company, PT Kimia Farma Tbk, which may provide insights into its overall carbon footprint. For the year 2022, PT Phapros Tbk disclosed Scope 1 emissions of approximately 0.55 kg CO2e and Scope 2 emissions from purchased electricity amounting to about 10,168,000 kg CO2e. This indicates a significant reliance on electricity, contributing to its overall emissions profile. The company has not set specific reduction targets or initiatives, nor does it participate in the Science Based Targets initiative (SBTi) or other climate pledges. As a current subsidiary of PT Kimia Farma Tbk, PT Phapros Tbk's climate commitments and emissions data may be influenced by the broader corporate strategies of its parent company. The absence of detailed emissions data for recent years highlights a potential area for improvement in transparency and accountability regarding climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 0.82 | 0.0 | 0.00 |
| Scope 2 | - | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pt Phapros Tbk is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
